Skip to content

Multi-functional Customized Depressing Tongue Oral Stent for Normal Tissue Protection and Assisted Patient Immobilization in Head and Neck Cancer Patients Undergoing Radiotherapy: A Clinical Study

Multi-functional Customized Depressing Tongue Oral Stent for Normal Tissue Protection and Assisted Patient Immobilization in Head and Neck Cancer Patients Undergoing Radiotherapy: A Clinical Study - The application of multifunctional oral stents in radiotherapy for head and neck cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078537
Enrollment
Unknown
Registered
2023-12-12
Start date
2024-01-12
Completion date
Unknown
Last updated
2024-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck cancer, head and neck malignant tumor

Interventions

The stent group:Oral stent
The non-stent group:None

Sponsors

Sun Yat-sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Pathologically diagnosed with nasopharyngeal cancer involving the nasal cavity and hard palate, nasal cavity cancer, paranasal sinus cancer, hard palate, and tongue cancer.Age 18 to 75 years, regardless of gender. Patients have signed an informed consent form and the related treatment consent form.Patients without oral diseases, significant difficulty in opening the mouth, or severe maxillofacial deformities.

Exclusion criteria

Exclusion criteria: Patients who cannot understand and comply with the requirements of the research protocol. Patients with oral diseases, significant difficulty in opening the mouth, or severe maxillofacial deformities. Patients with missing teeth affecting the stability and repeatability of the stent.

Design outcomes

Primary

MeasureTime frame
Oral mucositis;Positional Setup Errors;

Secondary

MeasureTime frame
Overall survival;Complication free survival rate;Disease-free survival, DFS;Distant Metastasis-Free Survival;

Countries

China

Contacts

Public ContactWei Luo

Sun Yat-sen University Cancer Center

luowei@sysucc.org.cn+86 138 0252 5907

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026